Literature DB >> 6263097

Survival of rheumatoid synovium implanted into nude mice.

C E Brinckerhoff, E D Harris.   

Abstract

The gross morphologic features, histologic features, and synthesis of collagenase and prostaglandin E2 by rheumatoid synovial cells injected into athymic nude mice were studied. A single cell suspension of 2 X 10(7) cells was inoculated subcutaneously into the dorsum of each mouse. In 8 out of 9 mice injected with cells from 6 different patients, rheumatoid synovial cells remained at the injection site for 20-30 days. During this time they became organized into a pannuslike structure with fibroblasts, occasional multinucleated cells, numerous blood vessels, and diffuse collagen fibers. No lymphocytes were seen. Compared with cells cultured in vitro at Day 0, removal, dissociation, and culture of the implanted material at Day 21 revealed a decrease in the percentage of dendritic (stellate) cells known to be associated with collagenase and PGE2 production. However, cells passed through nude mice retained the ability to synthesize both of these compounds. Implantation of rheumatoid synovium into nude mice may provide a way of studying factors influencing the proliferative and destructive lesion of rheumatoid arthritis.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6263097      PMCID: PMC1903851     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  23 in total

1.  Comparative growth of bovine lymphosarcoma cells and lymphoid cells infected with Theileria parva in athymic (nude) mice.

Authors:  A D Irvin; C G Brown; G K Kanhai; D A Stagg
Journal:  Nature       Date:  1975-06-26       Impact factor: 49.962

2.  Cytological identification of radiation-chimaeras.

Authors:  C E FORD; J L HAMERTON; D W BARNES; J F LOUTIT
Journal:  Nature       Date:  1956-03-10       Impact factor: 49.962

Review 3.  Clinical aspects of T- and B-lymphocytes in rheumatic diseases.

Authors:  R P Messner
Journal:  Arthritis Rheum       Date:  1974 Jul-Aug

4.  Heterotransplantation of human foetal organs to the mouse mutant nude.

Authors:  C O Povlsen; N E Skakkebaek; J Rygaard; G Jensen
Journal:  Nature       Date:  1974-03-15       Impact factor: 49.962

5.  Relation of cellular infiltration of rheumatoid synovial membrane to its immune response.

Authors:  M Ziff
Journal:  Arthritis Rheum       Date:  1974 May-Jun

6.  Collagenases (third of three parts).

Authors:  E D Harris; S M Krane
Journal:  N Engl J Med       Date:  1974-09-26       Impact factor: 91.245

7.  A mechanism for cartilage destruction in rheumatoid arthritis.

Authors:  E D Harris; D R DiBona; S M Krane
Journal:  Trans Assoc Am Physicians       Date:  1970

8.  Development of invasive tumors in the "nude" mouse after injection of cultured human melanoma cells.

Authors:  B C Giovanella; S O Yim; J S Stehlin; L J Williams
Journal:  J Natl Cancer Inst       Date:  1972-05       Impact factor: 13.506

9.  Radioimmunoassay of prostaglandins Falpha, E1 and E2 in human plasma.

Authors:  F Dray; B Charbonnel; J Maclouf
Journal:  Eur J Clin Invest       Date:  1975-07-29       Impact factor: 4.686

10.  Collagenases in human synovial fluid.

Authors:  E D Harris; D R DiBona; S M Krane
Journal:  J Clin Invest       Date:  1969-11       Impact factor: 14.808

View more
  15 in total

1.  The p53 status in juvenile chronic arthritis and rheumatoid arthritis.

Authors:  H Taubert; B Thamm; A Meye; F Bartel; A K Rost; D Heidenreich; V John; J Brandt; M Bache; P Würl; H Schmidt; D Riemann
Journal:  Clin Exp Immunol       Date:  2000-11       Impact factor: 4.330

2.  Synovial fibroblasts of patients with rheumatoid arthritis attach to and invade normal human cartilage when engrafted into SCID mice.

Authors:  U Müller-Ladner; J Kriegsmann; B N Franklin; S Matsumoto; T Geiler; R E Gay; S Gay
Journal:  Am J Pathol       Date:  1996-11       Impact factor: 4.307

3.  Induction and activation of procollagenase in rabbit synovial fibroblasts after treatment with active oxygen released by xanthine/xanthine oxidase.

Authors:  W Ehrlich; H Huser; H Kröger
Journal:  Rheumatol Int       Date:  1995       Impact factor: 2.631

4.  Anchorage-independent growth of synoviocytes from arthritic and normal joints. Stimulation by exogenous platelet-derived growth factor and inhibition by transforming growth factor-beta and retinoids.

Authors:  R Lafyatis; E F Remmers; A B Roberts; D E Yocum; M B Sporn; R L Wilder
Journal:  J Clin Invest       Date:  1989-04       Impact factor: 14.808

5.  Hyperplastic synoviocytes from rats with streptococcal cell wall-induced arthritis exhibit a transformed phenotype that is thymic-dependent and retinoid inhibitable.

Authors:  D E Yocum; R Lafyatis; E F Remmers; H R Schumacher; R L Wilder
Journal:  Am J Pathol       Date:  1988-07       Impact factor: 4.307

6.  2nd International meeting on synovium cell biology, physiology and pathology. Canterbury, United Kingdom, 21-23 September 1994. Proceedings and abstracts.

Authors: 
Journal:  Ann Rheum Dis       Date:  1995-06       Impact factor: 19.103

7.  Activation of synovial fibroblasts in rheumatoid arthritis.

Authors:  R W Kinne; E Palombo-Kinne; F Emmrich
Journal:  Ann Rheum Dis       Date:  1995-06       Impact factor: 19.103

8.  Decreased cell proliferation and PGE2 production by fibroblasts treated with a modified hexose sugar, amiprilose hydrochloride.

Authors:  C E Brinckerhoff
Journal:  Agents Actions       Date:  1990-06

9.  Inhibition of the induction of collagenase by interleukin-1 beta in cultured rabbit synovial fibroblasts after treatment with the poly(ADP-ribose)-polymerase inhibitor 3-aminobenzamide.

Authors:  W Ehrlich; H Huser; H Kröger
Journal:  Rheumatol Int       Date:  1995       Impact factor: 2.631

10.  Generation of three-dimensional pannus-like tissues in vitro from single cell suspensions of synovial fluid cells from arthritis patients.

Authors:  Samuel Solomon; Madhan Masilamani; Subhasis Mohanty; Jörg E Schwab; Eva-Maria Boneberg; Harald Illges
Journal:  Rheumatol Int       Date:  2003-06-17       Impact factor: 2.631

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.